Please login to the form below

Not currently logged in
Email:
Password:

UK digital coach for pharma appointed

In a government-backed initiative, Karen Winterhalter is to coach UK pharmaceutical companies in digital communications
In a government-backed initiative aimed at encouraging business to do more online, Karen Winterhalter, former EMEA managing director of healthcare at Burson Marsteller, is to coach UK pharmaceutical companies in digital communications. This role supports the 'Year of digital business growth', due to be launched in 2011 by ecademy and the Department of Business, Innovation and Skills (BIS).

Combining her extensive UK and global communications experience, Winterhalter will work with pharmaceutical companies to help individuals or brand teams understand the true value of social media, develop their online presence and overcome some of the mindset issues that are preventing them adapting and communicating effectively online with stakeholders.

Karen Winterhalter 
Karen Winterhalter


"In the highly regulated pharmaceutical environment that has traditionally been closed, controlled and selective in its communication, the use of social media may seem an impossibility," said Winterhalter. 

"To effectively engage in this environment and still remain within the regulations, companies need to adopt an open, random and support approach that moves away from the traditional 'tell-sell' way of communicating and that is where coaching is needed. Once they understand the why the rest will come easily," she continued.

6th January 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics